Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 1 - General processes for the preparation of peptides
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
05/2003
05/29/2003US20030100061 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/29/2003US20030100019 Supported membrane, preparation and uses
05/29/2003US20030100007 Detection of preferential binding agents; form peptide library, incubate target, recover peptide which bind to target, expose target to non-peptide binding agent, recover bound target, determine structure of nonpeptide binding agent
05/29/2003US20030100004 Solid supportfor us ein the detection of preferential particles in sample
05/29/2003US20030099983 Synthesis of cyclic polymer; obtain chemical monmers, incubate with substrate, synthesize, recover cyclic polymers
05/28/2003EP1314745A1 Process for preparing trityl group containing polystyrene resins
05/28/2003EP1314739A1 Process for renaturation of recombinant, disulfide containing proteins at high protein concentrations in the presence of amines
05/28/2003EP1314467A1 Composite chromatographic sorbent of mineral oxide beads with hydroxyapatite-filled pores
05/28/2003EP1313863A2 A recombinant monoclonal antibody to phosphotyrosine-containing proteins
05/28/2003EP1313857A2 Lipid metabolism molecules
05/28/2003EP1313854A2 Transporters and ion channels
05/28/2003EP1313849A2 Cloned cells, embryos, and avians and methods of producing them
05/28/2003EP1313755A1 Method and functional particles for carrying out chemical or biological reactions or syntheses
05/28/2003EP1313754A1 Nucleophile-stable thioester generating compounds, methods of production and use
05/28/2003EP1313753A2 Regulator gene and system useful for the diagnosis and therapy of osteoporosis
05/28/2003EP1313543A1 Device and methods for subdividing and filtering gel material and extracting molecules therefrom
05/28/2003EP1257586A4 Use of an anion exchange resin (epm-7) as solid support for peptide synthesis and affinity chromatography
05/28/2003EP1106626B1 Process for the preparation of regular glycopeptides
05/28/2003EP0928294B1 Method and apparatus for preparing an acellular red blood cell substitute
05/28/2003EP0788509B1 Therapeutic peptide derivatives
05/28/2003EP0750747B1 Identification of amino acids by mass spectrometry
05/28/2003EP0686162B1 Improved method for the refolding of proteins
05/28/2003CN1420927A Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens
05/28/2003CN1420128A Humanized anti-HER 2 monoclonal antibody, its preparation method and pharmaceutical composition thereof
05/28/2003CN1109557C Cetroretix lyophilisate and process for preparation thereof
05/27/2003US6570040 Chemoselective ligation
05/27/2003US6569999 Generating polypeptide; obtain sample of adjusted amino acid sequences, incubate with detergent, form complex, incubate with amylose, recover polypeptide
05/27/2003US6569993 Process for the preparation of resin-bound cyclic peptides
05/27/2003US6569382 Electroosmotic movement and attachment of microscale and nanoscale devices
05/27/2003US6569340 Manufacturing universal plasma from blood comprising serological Group A and/or Group B antibodies; contacting with a chromatography resin comprising corresponding Group A and/or Group B antigen
05/27/2003CA2274241C A process for purifying apolipoprotein a or apolipoprotein e from human plasma
05/27/2003CA2176229C Improved interferon polymer conjugates
05/27/2003CA2145169C A process for the purification of aqueous extracts containing allergenically active proteins, extracts obtainable according to this process as well as their use
05/27/2003CA2129442C Polyethylene or polypropylene glycol containing polymer
05/27/2003CA2031430C Process for refolding recombinantly produced tgf-.beta.-like proteins
05/22/2003WO2003042357A2 Enzymes
05/22/2003WO2003042249A2 Peptide purification by means of metal ion affinity chromatography
05/22/2003WO2003042236A1 Process for producing concentrated/purified protein using clay mineral composition
05/22/2003WO2003042235A2 Extended native chemical ligation of three or more peptide fragments
05/22/2003WO2003042233A2 Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry
05/22/2003WO2002099436A3 Characterising polypeptides
05/22/2003US20030096790 Bacterial antigens for an immunological test for infection of by a Grampositive bacterium; diagnosing infection associated with central venous catheters, prosthetic devices, and cerebrospinal fluid shunts
05/22/2003US20030096786 Methods of treating neurodegenerative or myelination disorders using prosaposin-derived peptides
05/22/2003US20030096386 Nuclelotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorder
05/22/2003US20030096359 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096358 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096357 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096346 Nucleic acids, proteins, and antibodies
05/22/2003US20030096320 Oil bodies and associated proteins as affinity matrices
05/22/2003US20030096297 Method for identifying inhibitors of G protein coupled receptor signaling
05/22/2003US20030096294 Automated method for setting up crystallization experiments employing a crystallization device identification code reader
05/22/2003US20030096293 Automated crystallization experiment setup apparatus comprising crystallization device identification code reader
05/22/2003US20030096226 Use of a native epitope for selecting evolved binding members from a library of mutants of a protein capable of binding to said epitope
05/22/2003US20030096225 Recovering preferential protein from library; obtain cell, transform with vector, express vector, isolate preferential protein
05/22/2003CA2466746A1 Extended native chemical ligation of three or more peptide fragments
05/22/2003CA2465214A1 Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry
05/22/2003CA2460959A1 Enzymes
05/21/2003EP1312680A1 Process for the synthesis of all-D-peptides and peptide nucleic acids
05/21/2003EP1312611A1 Method of continuously degrading protein
05/21/2003EP1311686A2 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization
05/21/2003EP1311536A2 Vaccine immunogens comprising disulphide bridged cyclised peptide and use thereof in the treatment of allergies
05/21/2003EP1311527A2 Novel strategie for synthesising polymers on surfaces
05/21/2003EP1311281A1 Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
05/21/2003EP1311242A1 Active agent delivery systems and methods for protecting and administering active agents
05/21/2003EP1230340A4 Methods and apparatus for the electronic, homogeneous assembly and fabrication of devices
05/21/2003EP1204675B1 Streptogramin derivatives, production thereof and compositions containing the same
05/21/2003EP1189932B1 Novel echinocandin derivatives, method for preparing the same and use as antifungal agents
05/21/2003EP1040151A4 Heterofunctionalized star-shaped poly(ethylene glycols) for protein modification
05/21/2003EP0877752B1 Methods for screening for transdominant effector peptides and rna molecules
05/21/2003EP0866801B1 Cyclopeptolides
05/21/2003EP0820285B1 Methods and compositions for lipidization of hydrophilic molecules
05/21/2003EP0720618B1 Process for the purification of basic fibroblast growth factor
05/21/2003EP0707650B1 Process for producing human relaxin
05/21/2003EP0575545B1 Pegylation of polypeptides
05/21/2003EP0411031B1 THE HUMAN C3b/C4b RECEPTOR (CR1)
05/21/2003CN1419566A A method of production of LgG
05/21/2003CN1418891A Nitrogen enclosing device for protein chromatography
05/21/2003CN1418890A Process for preparing momordic glucose-reducing polypeptide
05/21/2003CN1418889A Momordi glucose-reducing polypeptide
05/21/2003CN1109045C Process for preparation of virus-inactivated factor VIII-contg. fraction by chromatographic methods
05/21/2003CN1109041C Process for preparing substituted disulfide derivative and targeted form thereof
05/21/2003CN1108814C Process for manufacture of pharmaceutical composition containing polyethylene glycol protein conjugates
05/20/2003US6566515 Performing photochemical reactions on a surface; prepare chemical mixture, apply to surface, irradiate, monitor generation of reaction product
05/20/2003US6566504 Adding to the protein solution a cyclodextrin in an amount sufficient to form a stable complex with the protein, lyophilizing, recovering lyophilized protein/cyclodextrin complex, heating complex to inactivate viruses
05/20/2003US6566495 Biosynthesis of preferential biopolymers; provide substrate, electrically activate preferential positions, bind monomer, repeat, recover biopolymers
05/20/2003US6566491 Cyclopeptide derivatives
05/20/2003US6566330 Positively charged non-natural amino acids, methods of making and using thereof in peptides
05/20/2003US6566077 Qualitative or quantitative analysis of immunoglobulin; generate solid support, incubate with immunoglobulin mixture, wash microtiter plate, detect complexed immunoglobulin
05/20/2003US6566070 Detecting preferential protein biosynthesis; label nucleotide sequences, mix with translation system, incubate, detct signal from protein
05/20/2003CA2199515C Automated molecular biological diagnostic system
05/15/2003WO2003040726A2 Screening for hepatitis c virus entry inhibitors
05/15/2003WO2003040695A2 Protein knobs
05/15/2003WO2003040391A2 Method for producing and identifying soluble protein domains
05/15/2003WO2003040288A2 Isotopically coded affinity markers 3
05/15/2003WO2003040172A2 Methods and reagents for peptide-bir interaction screens
05/15/2003WO2003040166A2 Membrane adsorber device
05/15/2003WO2003040094A2 Methods for preparation of macrocyclic molecules macrocyclic molecules prepared thereby and substrates and solid supports for use therein
05/15/2003WO2003039346A2 Diagnostics and therapeutics for ocular abnormalities
05/15/2003WO2002097032A3 Proteins associated with cell growth, differentiation, and death
05/15/2003WO2002035241A3 High throughput screening for protein formulations
1 ... 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 ... 518